In a rat model of NAFLD using a high-fructose diet, a synbiotic formulation made up Lactobacillus fermentum CECT5716 and FOS, reduced liver steatosis and insulin resistance [102]. Here, FOS is linked to metabolic dysfunction-associated steatotic liver disease.